State public health director reports
1 probable case of injection-related meningitis in Illinois
Send a link to a friend
[October 16, 2012]
SPRINGFIELD -- Illinois
Department of Public Health Director LaMar Hasbrouck is reporting
one probable case of meningitis associated with the use of an
epidural steroid injection pain medication, but the investigation is
The probable case is a Chicago resident who received an epidural steroid
injection from one of three implicated lots of methylprednisolone acetate
originally recalled by the New England Compounding Centers. The person received
the injection at one of the three APAC Centers for Pain Management that received
the recalled medication. The person received the injection during the exposure
period set by the Centers for Disease Control and Prevention -- May 21 through
Sept. 26 -- and is undergoing further testing and treatment.
"The Illinois Department of Public Health continues to work with local and
federal officials investigating the multistate meningitis outbreak," said Dr.
Hasbrouck. "If you have received an epidural steroid injection and are
experiencing fever, worsening headache, stiff neck, sensitivity to light, new
numbness or weakness, or slurred speech, talk with your doctor as soon as
possible. This type of fungal meningitis is not contagious."
The CDC and Food and Drug Administration investigation found possible fungal
contamination of methylprednisolone acetate in three lots produced by the New
England Compounding Centers. The company has since recalled all of its products
going back to Jan. 1.
[to top of second column]
The only health provider in Illinois that received the recalled
product from NECC is APAC Centers for Pain Management. Three APAC
locations provided epidural steroid injections -- the Thorek
Hospital Professional Building and Lincoln Park location, both in
Chicago, and Prairie Medical Building in Westchester.
A hotline for APAC pain clinic patients has been established to
respond to patient concerns -- 708-699-5402. APAC estimates
approximately 350 people may have been exposed to the product. APAC
has contacted all but about a half-dozen of these clients and is
continuing to make efforts to reach them.
For more information, visit
Department of Public Health file received from
Illinois Office of
Communication and Information]